Pfizer tests new heart pill on healthy volunteers
NCT ID NCT07455240
Summary
This early-stage study aims to understand how a potential new heart failure medicine called PF-07328948 is processed by the body and whether it's safe to take. Ten healthy Chinese adults will take the oral medication daily for one week while researchers monitor their health. The main goal is to gather basic safety information and see how the drug moves through the body before testing it in people with heart failure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 101100, China
Conditions
Explore the condition pages connected to this study.